本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kiromic BioPharma, Inc.

0.1601
0.0000
成交量:- -
成交额:- -
市值:- -
市盈率:-0.01
高:0.1601
开:0.1601
低:0.1601
收:0.1601
52周最高:0.1601
52周最低:0.1601
股本:- -
流通股本:- -
量比:1.58
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-26.8188
每股收益(LYR):-64.4213
净资产收益率:-1129.81%
总资产收益率:-143.47%
市净率:0.00
市盈率(LYR):0.00

数据加载中...

2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/05

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/21

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/12

重要事件披露

Form 8-K - Current report
2024/01/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/15

重要事件披露

Form 8-K - Current report
2023/11/20

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2023/11/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/06

重要事件披露

Form 8-K - Current report
2023/10/04

重要事件披露

Form 8-K - Current report